Triac Therapy Improves Daily Caregiver Outcomes in Rare MCT8 Deficiency Trial
An exploratory post-hoc analysis of a phase 2 trial reveals that the thyroid hormone analogue Triac significantly improved caregiver-reported outcomes, ...
An exploratory post-hoc analysis of a phase 2 trial reveals that the thyroid hormone analogue Triac significantly improved caregiver-reported outcomes, ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.